Evidence map›Paper›PMID 24991004›Full record

ArticleJournal of virology2014

The rhesus rhadinovirus CD200 homologue affects immune responses and viral loads during in vivo infection.

Ryan D Estep, Stephanie D Rawlings, Helen Li, Minsha Manoharan, Elizabeth T Blaine, Megan A O'Connor, Ilhem Messaoudi, Michael K Axthelm, Scott W Wong

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Over-Expression of CD200 Predicts Poor Prognosis in Cutaneous Squamous Cell Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ryan D EstepVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Stephanie D RawlingsVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Helen LiVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Minsha ManoharanVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Elizabeth T BlaineVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Megan A O'ConnorVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Ilhem MessaoudiSchool of Medicine, University of California, Riverside, Riverside, California, USA.
Michael K AxthelmVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, USA.
Scott W WongVaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, USA Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, USA wongs@ohsu.edu.
Oregon Health & Science University · USOregon National Primate Research Center · USUniversity of California, Riverside · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
RHESUS HHV 8 HOMOLOGUE IN AIDS RELATED MALIGNANCIESR01CA075922 · NCI · OREGON REGIONAL PRIMATE RESEARCH CENTER · PI WONG, SCOTT W · 1997 to 2024
$16.7M
Viral Testing CoreU42OD010426 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Gregory A Dissen · 2013 to 2026
$6.0M
Establishment of Specific Free Rhesus and Pigtail Macques ColoniesU24OD010850 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI AXTHELM, MICHAEL K · 2012 to 2015
$2.7M
NCI NIH HHS CA075922NCI NIH HHS R01 CA075922NIH HHS 8P51OD011092-54NIH HHS OD010850NIH HHS P51 OD011092NIH HHS U24 OD010850NIH HHS U42 OD010426
6 · The paper itself

Abstract

unlabelledRhesus macaque rhadinovirus (RRV) is a gammaherpesvirus of rhesus macaque (RM) monkeys that is closely related to human herpesvirus 8 (HHV-8)/Kaposi's Sarcoma-associated herpesvirus (KSHV), and it is capable of inducing diseases in simian immunodeficiency virus (SIV)-infected RM that are similar to those seen in humans coinfected with HIV and HHV-8. Both HHV-8 and RRV encode viral CD200 (vCD200) molecules that are homologues of cellular CD200, a membrane glycoprotein that regulates immune responses and helps maintain immune homeostasis via interactions with the CD200 receptor (CD200R). Though the functions of RRV and HHV-8 vCD200 molecules have been examined in vitro, the precise roles that these viral proteins play during in vivo infection remain unknown. Thus, to address the contributions of RRV vCD200 to immune regulation and disease in vivo, we generated a form of RRV that lacked expression of vCD200 for use in infection studies in RM. Our data indicated that RRV vCD200 expression limits immune responses against RRV at early times postinfection and also impacts viral loads, but it does not appear to have significant effects on disease development. Further, examination of the distribution pattern of CD200R in RM indicated that this receptor is expressed on a majority of cells in peripheral blood mononuclear cells, including B and T cells, suggesting potentially wider regulatory capabilities for both vCD200 and CD200 that are not strictly limited to myeloid lineage cells. In addition, we also demonstrate that RRV infection affects CD200R expression levels in vivo, although vCD200 expression does not play a role in this phenomenon. IMPORTANCE: Cellular CD200 and its receptor, CD200R, compose a pathway that is important in regulating immune responses and is known to play a role in a variety of human diseases. A number of pathogens have been found to modulate the CD200-CD200R pathway during infection, including human herpesvirus 8 (HHV-8), the causative agent of Kaposi's sarcoma and B cell neoplasms in AIDS patients, and a closely related primate virus, rhesus macaque rhadinovirus (RRV), which infects and induces disease in rhesus macaque monkeys. HHV-8 and RRV encode homologues of CD200, termed vCD200, which are thought to play a role in preventing immune responses against these viruses. However, neither molecule has been studied in an in vivo model of infection to address their actual contributions to immunoregulation and disease. Here we report findings from our studies in which we analyzed the properties of a mutant form of RRV that lacks vCD200 expression in infected rhesus macaques.

Indexed as

Viral LoadAnimalsAntigens, CDHerpesviridae InfectionsLeukocytes, MononuclearMacaca mulattaMonkey DiseasesReceptors, ImmunologicRhadinovirusViral ProteinsAntigens, CDantigens, CD200Receptors, ImmunologicViral Proteins

Identifiers

PMID24991004
PMCPMC4178886
OpenAlexW2043688428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.